David Calkins Archives
Medical Center’s creative problem-solvers inspire others during Strategy Share 2023
Oct. 31, 2023—The ingenuity and enterprising spirit on display at Vanderbilt University Medical Center took center stage last week at Strategy Share 2023, as more than 30 employees presented their problem-solving and innovative solutions.
Major commitment bolsters Vanderbilt’s retinal vision research efforts
Sep. 22, 2022—A $10 million gift from the International Retinal Research Foundation will establish a center dedicated to retinal vision research at the Vanderbilt Eye Institute and a directorship to support a physician-scientist leader in the Department of Ophthalmology and Visual Sciences.
Calkins lands national award for research on blinding eye diseases
Sep. 8, 2022—Vanderbilt's David Calkins, PhD, has been selected by the Research to Prevent Blindness and Association of University Professors of Ophthalmology to receive the 2023 David F. Weeks Award for Outstanding Vision Research.
Calkins named Assistant VP for Research at VUMC
Dec. 10, 2020—David Calkins, PhD, director of the Vanderbilt Vision Research Center and vice chair and director for Research of the Department of Ophthalmology and Visual Sciences, has been appointed Assistant Vice President for Research at Vanderbilt University Medical Center.
StrategyShare2020 presents thought-provoking sessions
Oct. 7, 2020—Although the global COVID-19 pandemic forced StrategyShare2020 organizers to rapidly transform the event to an online-only format, there were no compromises in the quality and depth of the presentations, and more than 1,000 individuals registered to participate interactively, a record number for the annual event.
Study points to potential new approach to treating neurodegenerative diseases like glaucoma and Alzheimer’s disease
Jul. 20, 2020—Researchers at Vanderbilt University Medical Center have shown for the first time that when one optic nerve in the eye is damaged, as in glaucoma, the opposite optic nerve comes to the rescue by sharing its metabolic energy.
StrategyShare 2020 to proceed in virtual sessions
Jul. 15, 2020—New dates and a revised, virtual format have been announced for StrategyShare2020, with the first session on Sept. 29.
Eye Institute receives $10 million gift for vision research efforts
Jul. 25, 2019—The Vanderbilt Eye Institute (VEI) has received a $10 million gift that will fund regenerative visual neuroscience research to develop transformative therapies for eye diseases.
Calkins lands innovation award from Research to Prevent Blindness
Jun. 28, 2018—Jun. 28, 2018—David Calkins, PhD, vice chair and director of Research at the Vanderbilt Eye Institute, has been granted one of the preeminent awards in vision research — the Research to Prevent Blindness (RPB) Stein Innovation Award.
Glaucoma study finds brain fights to preserve vision
Feb. 22, 2018—A team of researchers, led by David Calkins, PhD, vice chair and director of Research at the Vanderbilt Eye Institute, has made a breakthrough discovery in the field of glaucoma showing new hopes for treatments to preserve vision.
Vision conference brings together research groups from across the Southeast
Oct. 5, 2017—The Vanderbilt Eye Institute (VEI) recently hosted the Southeastern Vision Conference to celebrate and share excellence in vision science.
A solar eclipse can hurt your eyesight without you knowing it – here’s why.
Aug. 15, 2017—While agreeing that viewing a total solar eclipse is a chance of a lifetime, Vanderbilt Eye Institute Research Director David Calkins urges us to not look at the sun without special eclipse glasses. Catkins explains how certain spectrums of sunlight can damage your eyesight without you knowing it, until it is too late. Follow Vanderbilt...
